Table 3.
HP | Adenoma | SSA | Study |
---|---|---|---|
16.9% (11/65) | - | 39.2% (20/51) | Fujita et al. [60] |
- | 10% (1/10) | - | Krishn et al. [61] |
- | 15.8% (3/19) | 20% (2/10) | Perçinel et al. [68] |
0% (0/9) | 16% (4/25) | - | Bartman et al. [84] |
4.3% (1/23) | 0% (0/63) | 51.6% (16/31) | Kim et al. [87] |
0% (0/48) | - | 100% (26/26) | Owens et al. [92] |
17.4% (16/92) | 0% (0/87) | 53.5% (23/43) | Bartley et al. [93] |
HP = Hyperplastic polyp, SSA = Sessile serrated adenoma.